DDB allows ordinary prescriptions for dangerous drugs until June 2026

The Dangerous Drugs Board (DDB) has temporarily allowed the use of ordinary prescriptions for dangerous drugs until June 30, 2026, to improve patient access to treatment for pressing health concerns.

This temporary measure, outlined in Board Regulation No. 10, Series of 2025, responds to public health situations like the spread of Mpox, a resurgence of Covid-19, and rising HIV infections.

Under the new regulation, medical practitioners with a valid S2 license can issue triplicate copies of ordinary prescriptions for dangerous drugs, replacing the usual DOH-issued yellow prescription forms.

Each prescription issued must contain only one dangerous drug or preparation, and physicians can prescribe a supply lasting up to 30 days.

DDB Chairperson Secretary Oscar Valenzuela stated that this regulatory flexibility is part of the government's broader response to ensure uninterrupted care for patients.

The measure aligns with World Health Organization recommendations and addresses a reported 500% increase in HIV among Filipino youths.